top of page
LifeTherepeautics LOGO
Eddie Sadan Ariel Werman.jpg
Eddie Sadan,
Ariel Werman

Founders

Terrapeutics developed a groundbreaking platform discovery technology that combines synthetic biology, sequencing tools, and computational biology to discover novel small molecules produced by soil-based bacteria that tackle ‘undruggable’ targets.

Terrapeutics’ lead discovery program focuses on pan KRAS inhibitors, the next generation of therapeutic solutions for a drug target whose mutations drive 25% of cancers. The company is working on additional programs that will be announced in the near future. The company has R&D operations in California and Israel.

stripBIG-01.jpg

PORTFOLIO

Product
icon-08.png

DEVICES

icon-09.png
icon-07.png

PHARMA & BIOTECH

icon-10.png
icon-06.png

PHARMA & BIOTECH

icon-11.png
bottom of page